Kassim Hassoon Ali, Faruk H. Al-Jawad, Haitham Mahmood Kadhim
Kassim Hassoon Ali1*, Faruk H. Al-Jawad2, Haitham Mahmood Kadhim3
1Department of Pharmacology & Toxicology, College of Pharmacy, Al-Mustansiriyah, University, Baghdad Iraq.
2Department of Pharmacology &Therapeutics, College of Medicine, Al-Nahrain University, Baghdad-Iraq.
3Department of Pharmacology & Toxicology, College of Pharmacy, Al-Nahrain University, Baghdad-Iraq.
Volume - 14,
Issue - 11,
Year - 2021
Liver fibrosis is considered now as one of the most spread disease worldwide. It is attributed to different underlying causative agents such as viral infections, ethanol-induced liver steatosis, and non-ethanol-induced hepatic steatosis, autoimmune and inherited disorders. Hepatic fibrosis was known to behave as tissue repair mechanism in which the initiation occurred through complicated series of interrelated and regulated signaling. These signals involved interactions between different types of cells. Among these cells are hepatocytes, non-parenchymal cells such as hepatic stellate cells (HSCs), liver sinusoidal endothelial cells, Kupffer cells, biliary epithelial cells, liver associated lymphocytes, and the non-resident infiltrating immune cells. current work was aimed to investigate the possible potential hepatopretective effects of krill oil alone and in combination with silymarin against Carbone tetrachloride-induced liver fibrosis/injury in white albino rats. Moreover, fifty white albino rats of both genders were utilized in this study. During such study liver fibrosis/damage was induced by intraperitoneal (I.P) injection of Carbone tetrachloride (CCl4) 50% in olive oil 1ml/kg twice weekly for 6 consecutive weeks in the induction group. Krill oil alone and in combination with silymarin was administered orally concurrently with I.P CCl4 for 6 consecutive weeks in the treatment groups. At the end of treatment period all animals were killed ,serum and tissue samples were collected for subsequent analyses. Serum levels of aminotransferases (ALT,AST), albumin , total serum bilirubin (T.S.B), and total anti-oxidant capacity were measured spectrophotometrically. In addition tissue level (content) of liver hudroxyproline content (Hyp) was determined by ELISA and relative liver weight percentage (R.L.W%) was also estimated.Results were significantly revealed that krill oil potentiate the hepatoprotective effects of silymarin against Carbone tetrachloride-induced liver fibrosis/injury.
Cite this article:
Kassim Hassoon Ali, Faruk H. Al-Jawad, Haitham Mahmood Kadhim. The Possible Hepatoprotecive Effects of ''Krill Oil and Silymarin against Carbon Tetrachloride (CCl4)-Induced Rats Model of Liver Fibrosis: In Vivo Study''. Research Journal of Pharmacy and Technology. 2021; 14(11):5953-8. doi: 10.52711/0974-360X.2021.01034
Kassim Hassoon Ali, Faruk H. Al-Jawad, Haitham Mahmood Kadhim. The Possible Hepatoprotecive Effects of ''Krill Oil and Silymarin against Carbon Tetrachloride (CCl4)-Induced Rats Model of Liver Fibrosis: In Vivo Study''. Research Journal of Pharmacy and Technology. 2021; 14(11):5953-8. doi: 10.52711/0974-360X.2021.01034 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-11-60
1. Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells. 2020; 9(4):875:1-43.
2. Mehta KJ, Farnaud SJ, Sharp PA. Iron and liver fibrosis: Mechanistic and clinical aspects. World J Gastroenterol. 2019; 25(5): 521-538.
3. Cheng J.Y-K, Wong G. L-H. Advances in the diagnosis and treatment of liver fibrosis. Hepatoma Res. 2017; 3: 156-169.
4. Teschke R. Intoxications by aliphatic halogenated hydrocarbons: hepatotoxic risks for patients and clinical issues including role of CO2- induced hyperventilation as therapy option. Review. Journal of Clinical and Experimental Toxicology. 2018; 2(1): 25-29.
5. Fortea J. I, Fernandez-Mena F., Puerto M., Ripoll C., Almargo J., Banares J., Bellon J.B., Banares R., and Vaquero J. Comparison of Two Protocols of Carbon Tetrachloride- Induced Cirrhosis in Rats-Improving Yield and Reproducibility. Sci Rep. 2018; 8, 9163:1-10.
6. Al-Jawad FH, Al-Attar Z, Abbood, MS. The Protective Effect of Nitroglycerin, N-Acetyl Cysteine and Metoprolol in CCL4 Induced Animal Model of Acute Liver Injury. Open Access Maced J Med Sci. 2019; 7(11):1739-1743.
7. Nathwani R., Mullish B.H, Kockerling D., Forlano R., Pinelopi M., and Dhar A. A Review of Liver Fibrosis and Emerging Therapies. Review. European Medical Journal. 2019; 4(4): 105-116.
8. Guo YC and Lu LG. Antihepatic Fibrosis Drugs in Clinical Trials. Review. J Clin Transl Hepatol. 2020; 8(4):1–9.
9. Kołota A, Głąbska D, Oczkowski M, and Gromadzka-Ostrowska J. Oxidative Stress Parameters in the Liver of Growing Male Rats Receiving Various Alcoholic Beverages. Nutrients. 2020; 12(1):1-14.
10. Sushama D. P, Patil L, Kadam V.J. Protective Effect of Ethanolic Extract of Fruit of Luffa aegyptiaca Mill. on Carbon Tetrachloride Induced Hepatotoxicity in Rats. Research J. Pharm. and Tech. 2011;4(6): 938-941.
11. Shukla A., P. Bigoniya P. Hepatoprotective Effect of Lepidium Sativum Linn (Cruciferae) Total Alkaloid Fraction against CCl4 Induced Hepatotoxicity on Rats. Research J. Pharmacognosy and Phytochemistry.2013; 5(2): 94-99.
12. Sahu S. K., Das D., Tripathy N. K.. Hepatoprotective activity of aerial part of Glinus oppositifolius L. against Paracetamol-induced Hepatic Injury in Rats. Asian J. Pharm. Tech.2012; 2(4): 154-156.
13. Patel J, Reddy V., Kumar G.S. Evaluation of hepatoprotective activity of ethanolic extract of Diospyros melanoxylon (Roxb) leaves against CCl4 induced hepatotoxicity in albino rats. Research J. Pharm. and Tech. 2015;8(5): 571-574.
14. Vijayakumar K., and Anand A.V. Protective Effects of Psidium guajava and its Isolated Fraction on CCl4 Induced Oxidative Stress. Research J. Pharm. and Tech 2016; 9(8):1155-1160.
15. Nasir F.S, Jaffat H.S. Effect of Royal Jelly against Carbon Tetrachloride (CCl4) Induced Toxicity in Male Rats. Research J. Pharm. and Tech. 2017; 10(8): 2479-2486.
16. Ismail R. S.A, El-Megeid A.A.A, and Abdel-Moemin A. R. Carbon tetrachloride-induced liver disease in rats: the potential effect of supplement oils with vitamins E and C on the nutritional status. GMS German Medical Science. 2009, Vol. 7:1-10.
17. Tiwari P., Kumar P., Panik R., Pandey A., Sahu P.K. Hepatoprotective Potentials of Butea monosperma Stem Bark Extract against Carbon Tetrachloride Induced Hepatotoxicity in Albino Rats. Research J. Pharmacology and Pharmacodynamics. 2011; 3(5): 281-284.
18. Chandrasekhar R B, Krishnaveni B, Krishna M.G., Jithan AV. Preparation, Characterization and In Vivo Evaluation of Dexamethasone Nanoparticles for the treatment of Liver Fibrosis. Research J. Pharm. and Tech. 2020; 13(12):6098-6104.
19. Taamalli A., Feriani A., Lozano-Sanchez J., Ghazouani L., El Mufti A., et al. Potential Hepatoprotective Activity of Super Critical Carbon Dioxide Olive Leaf Extracts against CCl4-Induced Liver Damage. Foods 2020; 9(804): 1-18.
20. Anoopa JL, Kannappan N, Manojkumar P. Evaluation of Hepatoprotective activity in methanolic extract of Aerial parts of Hibiscus surattensis. Research J. Pharm. and Tech. 2020; 13(10):4635-4640.
21. Zamzami M.A., Baothman O. A. S., Samy F., and Abo-Golayel M. K. Amelioration of CCl4-Induced Hepatotoxicity in Rabbits by Lepidium sativum Seeds. Evidence-Based Complementary and Alternative Medicine 2019; Volume 2019(Article ID 5947234): 1-17.
22. Rajkumar S. Bagali, Sunil S. Jalalpure, S. S. Patil. Evaluation of Schrebera swietenioides Roxb. fruit Ethanolic extract for Antioxidant and Hepatoprotective activity against CCl4 induced liver injury in rats. Research J. Pharm. and Tech. 2020; 13(11):5115-5120.
23. Eltahir HM, Fawzy MA, Mohamed EM, Alrehany MA, Shehata AM and Abouzied MM: Antioxidant, anti inflammatory and anti fibrotic effects of Boswellia serrate gum resin in CCl4 induced hepatotoxicity. Exp Ther Med. 2020; 19(2): 1313-1321.
24. Sun W., Shi B., Xue C., and Jiang Z. Effective Antarctic krill oil extraction using switchable hydrophilicity solvents. Mar Life Sci Technol. 2020; 2: 41–49.
25. Helal M.G, El-Kashef D.H. Krill oil alleviates oxidative stress, iron accumulation and fibrosis in the liver and spleen of iron-overload rats. Environ Sci Pollut Res. 2020; 27:3950-3961.
26. Levick C. How to interpret liver function tests. South Sudan Medical Journal. 2017; 10(2): 40-43.
27. Lee S. IL, Valim C., Johnston P., Le H.D., Meisel J., Arsenault D.A., Gura K.M, and Puder M. The Impact of Fish Oil-Based Lipid Emulsion on Serum Triglycerides, Bilirubin, and Albumin Level in Children with Parenteral Nutrition-Associated Liver Disease. Pediatr Res. 2012; 66(6): 698-703.
28. Shen M., Chen K., Lu J., Cheng P., Xu L., et al. Protective Effect of Astaxanthin on Liver Fibrosis through Modulation of TGF-𝛽1 Expression and Autophagy. Mediators of Inflammation 2014; Volume 2014(Article ID 954502): 1-14.
29. Xu Y., Sun X., Zhang R., Zhang X., Li D., et al. A Positive Feedback Loop of TET3 and TGF-b1 Promotes Liver Fibrosis. Cell Reports. 2020; 30: 1310–1318.
30. Gabr S.A., Alghadir A.H., Sherif Y.E., and Ghfar A.A. Hydroxyproline as a Biomarker in Liver Disease. In: V.R Pready (Ed). Biomarkers in Liver Disease, Biomarkers in Disease: Methods, Discoveries and Applications. Springer Science + Business Media; 2016:1-21.
31. Burri L., Hoem N., Banni S., and Berge K. Marine Omega-3 Phospholipids: Metabolism and Biological Activities (Review). Int. J. Mol. Sci. 2012; 13: 15401-15419.
32. Zhang, X., Han, X., Yin, L., Xu L., Qi Y., et al. Potent effects of dioscin against liver fibrosis. Sci Rep. 2015; 5(9713): 1-11.
33. Tandy S., Chung R.W.S, Wat E., Kamili A., Berge K., et al.,2009. Dietary Krill Oil Supplementation Reduces Hepatic Steatosis, Glycemia, and Hypercholesterolemia in High-Fat-Fed Mice. J. Agric. Food Chem. 2009, 57, 9339–9345.
34. Sistilli G., Kalendova V., Cajka T. , a Irodenko I., Bardova K., et al.,. Krill Oil Supplementation Reduces Exacerbated Hepatic Steatosis Induced by Thermoneutral Housing in Mice with Diet-Induced Obesity. Nutrients. 2021;13 (437): 1-24.